Wednesday, June 24, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 904 of 1,261

  1. US 8278272

    GLP-1, exendin-4, peptide analogs and uses thereof

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Oct 2, 2012 · Expires Sep 27, 2032

    granted

  2. US 8278083

    Inactivated influenza virus compositions

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Oct 2, 2012 · Expires Sep 27, 2032

    granted

  3. US 8277796

    Regeneration and repair of neural tissue using postpartum-derived cells

    Advanced Technologies and Regenerative Medicine, LLC · Granted Oct 2, 2012 · Expires Sep 27, 2032

    granted

  4. US 8278297

    Protein kinase inhibitors

    Vertex Pharmaceuticals Incorporated · Granted Oct 2, 2012 · Expires Sep 27, 2032

    granted

  5. US 8278306

    C-met protein kinase inhibitors

    Vertex Pharmaceuticals Incorporated · Granted Oct 2, 2012 · Expires Sep 27, 2032

    granted

  6. US 8273724

    Melanoma antigens and their use in diagnostic and therapeutic methods

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Sep 25, 2012 · Expires Sep 20, 2032

    granted

  7. US 8273869

    Lipid formulated dsRNA targeting the PCSK9 gene

    Alnylam Pharmaceuticals, Inc. · Granted Sep 25, 2012 · Expires Sep 20, 2032

    granted

  8. US 8274643

    Porous nanostructures and methods involving the same

    The Regents of the University of California · Granted Sep 25, 2012 · Expires Sep 20, 2032

    granted

  9. US 8275594

    Engineered scaffolds for intervertebral disc repair and regeneration and for articulating joint repair and regeneration

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Sep 25, 2012 · Expires Sep 20, 2032

    granted

  10. US 8273868

    Compositions and methods for inhibiting viral replication

    Alnylam Pharmaceuticals, Inc. · Granted Sep 25, 2012 · Expires Sep 20, 2032

    granted

  11. US 8273867

    Transducible delivery of siRNA by dsRNA binding domain fusions to PTD/CPPS

    The Regents of the University of California · Granted Sep 25, 2012 · Expires Sep 20, 2032

    granted

  12. US 8273833

    Branched Polymers

    Nektar Therapeutics · Granted Sep 25, 2012 · Expires Sep 20, 2032

    granted

  13. US 8273797

    Treating renal cancer using 4-[bis[2-[(methylsulfonyl)oxy]ethyl]amino]-2-methyl-benzaldehyde

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Sep 25, 2012 · Expires Sep 20, 2032

    granted

  14. US 8273786

    3-phenoxymethylpyrrolidine compounds

    Theravance, Inc. · Granted Sep 25, 2012 · Expires Sep 20, 2032

    granted

  15. US 8273761

    Tricyclic compound and medical use thereof

    Takeda Pharmaceutical Company Limited · Granted Sep 25, 2012 · Expires Sep 20, 2032

    granted

  16. US 8273751

    Organic compounds

    Takeda Pharmaceutical Company Limited · Granted Sep 25, 2012 · Expires Sep 20, 2032

    granted

  17. US 8273746

    Methods involving aldose reductase inhibitors

    The Board of Regents of the University of Texas System · Granted Sep 25, 2012 · Expires Sep 20, 2032

    granted

  18. US 8273750

    Organic compounds

    Takeda Pharmaceutical Company Limited · Granted Sep 25, 2012 · Expires Sep 20, 2032

    granted

  19. US 8273729

    Treatment of irritable bowel syndrome and related bowel disease

    The Board of Regents of the University of Texas System · Granted Sep 25, 2012 · Expires Sep 20, 2032

    granted

  20. US 8273741

    Imidazo-pyridazinyl compounds and uses thereof

    Takeda Pharmaceutical Company Limited · Granted Sep 25, 2012 · Expires Sep 20, 2032

    granted

  21. US 8273709

    Triazole-containing macrocyclic HCV serine protease inhibitors

    Enanta Pharmaceuticals, Inc. · Granted Sep 25, 2012 · Expires Sep 20, 2032

    granted

  22. US 8273339

    Polymer-based compositions and conjugates of antimicrobial agents

    Nektar Therapeutics · Granted Sep 25, 2012 · Expires Sep 20, 2032

    granted

  23. US 8273896

    Processes for producing phenyl-6-(1-(phenyl)ureido)nicotinamides

    Vertex Pharmaceuticals Incorporated · Granted Sep 25, 2012 · Expires Sep 20, 2032

    granted

  24. US 8273351

    Fc receptor binding proteins

    Syntonix Pharmaceuticals, Inc. · Granted Sep 25, 2012 · Expires Sep 20, 2032

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.